MWMatthias Wittstock

Matthias Wittstock

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matthias Wittstock has a total of 278 co-authors. Here are the top co-authors by number of shared publications:

  • Uwe Walter

    Department of Neurology, Rostock University Medical Center, Rostock, Germany

    10 shared publications
  • Annette Grossmann

    From the Department of Neurology (U.W., M.F., A.S., M. Wittstock), Rostock University Medical Center, Rostock, Germany; Institute of Diagnostic and Interventional Radiology, Pediatric Radiology and Neuroradiology (A.G.), Rostock University Medical Center, Rostock, Germany; Institute of Clinical Chemistry and Laboratory Medicine (M. Walter), Rostock University Medical Center, Rostock, Germany; and Institute of Immunology and Transfusion Medicine (T.T.), Greifswald University Medical Center,...

    8 shared publications
  • Reiner Benecke

    From the Department of Neurology (U.W., C.M., R.B., E.M., J.A., M.W., A.D., A.S., C.K.), University of Rostock; German Centre for Neurodegenerative Diseases (DZNE) (U.W., A.S.), Rostock; and Movement Disorders Section, Department of Neurology (D.D.), Hannover Medical School, Germany

    7 shared publications
  • Alexander Storch

    Department of Neurology, University Medical Center Rostock

    6 shared publications
  • Albrecht Günther

    Department of Neurology, University Hospital Jena, Jena, Germany

    5 shared publications
  • Daniel Cantré

    Institute of Diagnostic and Interventional Radiology, Pediatric Radiology and Neuroradiology, University Medical Center Rostock

    4 shared publications

Latest Publications

  • Open Access

    Prognosis of acute symptomatic seizures and impact of prolonged treatment with anti‐seizure medication

    by Hannah Traben, Julia Herzig-Nichtweiß, Lisa Langenbruch, Felix Kohle, Johann O. Pelz, Piergiorgio Lochner, Matthias Wittstock, Albrecht Günther, Angelika Alonso, Marko Blickhan, et al.

    Objectives: Acute symptomatic epileptic seizures (ASySs) occur in temporal proximity to acute brain insults. Given their low risk of subsequent unprovoked seizures, current guidelines recommend either no treatment with anti‐seizure medication (ASM) or early discontinuation, yet ASM treatment is often continued beyond hospital discharge. We aimed at investigating the cumulative 3‐year risk and predictors of unprovoked seizures after ASySs and assessing the effect of ASM treatment duration. Methods: The prospective, multicenter register on the prognosis of acute symptomatic seizures (PROSE register) recruited adults with clinically apparent, acute symptomatic, first‐ever epileptic seizure, excluding status epilepticus. Primary endpoint was occurrence of a first unprovoked seizure. The impact of ASM treatment duration was assessed through a Cox regression correcting for treatment selection bias. The chance of occurrence of a seizure in the next year (COSY) was calculated to evaluate driving eligibility. Results: The 3‐year cumulative incidence of unprovoked seizures was 14% [95% confidence interval (CI): 7%–21%] among 122 participants with structural etiologies. Male sex (hazard ratio [HR] 9.3; 95% CI 1.9–45.1), early epileptiform electroencephalography (EEG) activity (HR 7.4; 95% CI 1.8–31.1), and latency ≥48 h between onset of underlying condition and ASyS (HR 4.8; 95% CI 1.3–18.1) were independently associated with unprovoked seizures. ASM treatment duration had no apparent effect (HR 1; 95% CI 1–1; p = .84). The initial COSY was 10% and fell below 2% within 2 years. Significance: Even in structural etiologies, ASySs bear a relatively low risk of later unprovoked seizures. There is still no evidence favoring prolonged ASM treatments. These findings may help preventing ASM overtreatment and guide counseling on driving eligibility.

  • A platform for near real-time and multiplexed monitoring of cerebrospinal fluid biomarkers and flow in neurocritical care

    by Fatemeh Keyvani, Luisa M. Muller, Natalie Fudge, Bridget MacLean, Agosh Saini, Joshua Khatri, Thomas Kriesen, Matthias Wittstock, Florian A. Gessler, Robert Langer, et al.

    Real-time monitoring of cerebrospinal fluid (CSF) is critical in intensive care units for the timely management of complications such as infection and mechanical malfunction in patients with external ventricular drainage systems. Current practice relies on intermittent CSF sampling for laboratory-based biomarker analysis and manual inspection, resulting in delayed reporting and intervention. To address these limitations, we developed NeuroSense, a multiplexed sensing platform that integrates with standard external ventricular drainage systems to enable near real-time monitoring of key CSF (bio)markers, including glucose, lactate, pH, and flow rate, that are essential for detecting infection and drain dysfunction. NeuroSense incorporates glucose and lactate aptamer–based electrochemical biosensors, a polydopamine pH sensor, and an impedance-based flow sensor. Validation in simulated conditions demonstrated sensor specificity, stability in human CSF for several days, and ethylene-oxide sterilization compatibility. Evaluation in patients hospitalized in intensive care unit demonstrated strong correlation with clinical reference standards. By providing near real-time bedside assessment, NeuroSense has the potential to improve temporal resolution for detection of biomarker trends and drain malfunction indicators.


  • Open Access

    Sarcopenia and ischemic stroke outcomes after endovascular revascularization: results of a retrospective, cohort study

    by Lea Maria Bumann, Bijan Zendeh Zartoshti, Ulrike Voßmann, Daniel Cantré, Artem Rafaelian, Daniel Dubinski, Alexander Storch, Matthias Wittstock

    Stroke is a major cause of disability and mortality, with its incidence increasing with age. Despite advances in acute stroke treatment, functional outcomes in elderly patients are not always as favorable as expected. Therefore, additional efforts are required to identify reliable prognostic markers and improve patient outcomes. Sarcopenia has been recognized as a negative factor influencing functional outcomes after ischemic stroke. Temporalis muscle thickness (TMT), assessed on routine imaging, has emerged as a potential surrogate marker for sarcopenia; however, its prognostic value in stroke patients has not yet been conclusively established. This study aimed to evaluate the association between TMT and functional outcome, assessed using the modified Rankin Scale (mRS) at hospital discharge, and in-hospital death. In this retrospective cohort study, we included 152 consecutive patients (median age, 74 years [IQR, 63–83]; 53% male) admitted to the Department of Neurology at the University of Medicine Rostock who underwent endovascular revascularization (EVT) for acute ischemic stroke. TMT was determined from initial cranial CT scans. Due to the small sample size, we used a uniform TMT cutoff value (5.78 mm) for sarcopenia. The primary endpoint was the mRS at discharge. Sarcopenic patients were older ( p < 0.001), more often female ( p < 0.001), and had a lower BMI ( p = 0.045). They also had significantly worse functional outcomes ( p = 0.006) and higher comorbidity burdens (atrial fibrillation, p = 0.023; arterial hypertension, p = 0.024; smoking, p = 0.020). Poor outcome was significantly associated with sarcopenia, but this association lost significance after adjustment. In the group comparison regarding mortality, deceased patients had lower TMT and were more frequently sarcopenic. However, these associations also lost significance in the multivariate model.

  • Open Access

    Prognostic value of temporalis muscle thickness as a marker of sarcopenia in intracerebral hemorrhage

    by Waldemar Gubarev, Jan Klinke, Ulrike Voßmann, Daniel Cantré, Bijan Zendeh Zartoshti, Artem Rafaelian, Milos Arsenovic, Daniel Dubinski, Sae-Yeon Won, Florian Gessler, et al.

    Introduction: Estimating the prognosis of spontaneous intracerebral hemorrhage (ICH) is of great importance. It has not been conclusively clarified whether sarcopenia is predictive for the functional outcome in ICH. Determining the temporalis muscle thickness (TMT) may be helpful for estimating sarcopenia. An association of TMT with outcome (mRS) has been shown in cerebellar ischemia and traumatic brain injury.Methods: The present retrospective study of 488 consecutive patients with ICH aimed to investigate the association of sarcopenia as assessed by TMT with mRS. In addition to biometric data, ICH subtype and severity [modified ICH score (mICH)], occurrence of complications and mRS at discharge and after 90 days were recorded. The influence of sarcopenia assessed by TMT as the surrogate marker using head imaging (cCT, cMRT) on mRS was analyzed by ordinal regression analysis. Dichotomization into sarcopenic and non-sarcopenic patients was carried out using standard threshold values.Results: Finally, 322 patients were analyzed [median (IQR) age: 77 (66–83) years; 57.5% male]. Sarcopenic patients were older (P < 0.001), had lower BMI (P = 0.025) and higher mICH scores (P < 0.001) compared to non-sarcopenic patients. There was no significant difference in the overall distribution of mRS scores between sarcopenic and non-sarcopenic patients at discharge (unadjusted common OR: 1.28; 95% CI: 0.85–1.92; P = 0.236), but at 90 days favoring the non-sarcopenic over the sarcopenic group (unadjusted common OR: 1.41; 95% CI: 1.07–2.12; P = 0.049). The results did not subsist statistical adjustment to candidate covariates by multivariate ordinal regression.Discussion: In conclusion, sarcopenia as assessed by TMT seems to have limited prognostic value in ICH.


  • Open Access

    Cranioplasty after Decompressive Craniectomy (DC) in a Patient with Intracerebral Hemorrhage after SARS-CoV-2 Vaccination-Related Vaccine-Induced Thrombotic Thrombocytopenia (VITT)—Proposal of a Management Protocol for This Rare Pathological Condition

    by Lennard Spanehl, Uwe Walter, Thomas Thiele, Daniel Dubinski, Bedjan Behmanesh, Thomas M. Freiman, Matthias Wittstock, Patrick Schuss, Hartmut Vatter, Matthias Schneider, et al.

    The COVID-19 (coronavirus disease) pandemic had a severe impact on public health worldwide. A rare but serious complication after administration of adenoviral vaccines against SARS-CoV-2 (AstraZeneca–Oxford and Johnson & Johnson) is vaccine-induced immune thrombotic thrombocytopenia and thrombosis (VITT), which can lead to serious complications such as cerebral venous sinus thrombosis (CVST). CVST itself can cause subarachnoid hemorrhage (SAH) and/or intracerebral hemorrhage (ICH), leading to high mortality due to herniation of brain parenchyma. In those patients, an emergent decompressive hemicraniectomy (DC) is regularly performed. Herein, the authors want to focus on the patients who survive DC following VITT-associated CVST and shed light on the neurosurgical considerations in those patients. We herein propose a treatment algorithm regarding the timing and the perioperative management of cranioplasty. We describe an exemplary case highlighting that special circumstances may result in a more urgent need for autologous cranioplasty than usual, based on individual risk assessment.


  • Open Access

    Head movement dynamics in dystonia: a multi-centre retrospective study using visual perceptive deep learning

    by Robert Peach, Maximilian Friedrich, Lara Fronemann, Muthuraman Muthuraman, Sebastian R. Schreglmann, Daniel Zeller, Christoph Schrader, Joachim K. Krauss, Alfons Schnitzler, Matthias Wittstock, et al.

    Dystonia is a neurological movement disorder characterised by abnormal involuntary movements and postures, particularly affecting the head and neck. However, current clinical assessment methods for dystonia rely on simplified rating scales which lack the ability to capture the intricate spatiotemporal features of dystonic phenomena, hindering clinical management and limiting understanding of the underlying neurobiology. To address this, we developed a visual perceptive deep learning framework that utilizes standard clinical videos to comprehensively evaluate and quantify disease states and the impact of therapeutic interventions, specifically deep brain stimulation. This framework overcomes the limitations of traditional rating scales and offers an efficient and accurate method that is rater-independent for evaluating and monitoring dystonia patients. To evaluate the framework, we leveraged semi-standardized clinical video data collected in three retrospective, longitudinal cohort studies across seven academic centres. We extracted static head angle excursions for clinical validation and derived kinematic variables reflecting naturalistic head dynamics to predict dystonia severity, subtype, and neuromodulation effects. The framework was also applied to a fully independent cohort of generalised dystonia patients for comparison between dystonia sub-types. Computer vision-derived measurements of head angle excursions showed a strong correlation with clinically assigned scores. Across comparisons, we identified consistent kinematic features from full video assessments encoding information critical to disease severity, subtype, and effects of neural circuit interventions, independent of static head angle deviations used in scoring. Our visual perceptive machine learning framework reveals kinematic pathosignatures of dystonia, potentially augmenting clinical management, facilitating scientific translation, and informing personalized precision neurology approaches.


  • Open Access

    An anti-PF4 antibody-related disorder with cerebral venous sinus thrombosis and thrombocytopenia initially presenting as intracranial hemorrhage

    by Matthias Wittstock, Daniel Cantré, Sae-Yeon Won, Alexandra V. Jürs, Jan Wesche, Nico Greger, Andreas Greinacher, Thomas Thiele


  • Open Access

    Frailty in Traumatic Brain Injury—The Significance of Temporal Muscle Thickness

    by Daniel Dubinski, Sae-Yeon Won, Jonas Meyer-Wilmes, Svorad Trnovec, Artem Rafaelian, Bedjan Behmanesh, Daniel Cantré, Peter Baumgarten, Nazife Dinc, Juergen Konczalla, et al.

    Background: Temporal muscle thickness (TMT) on cranial CT scans has recently been identified as a prognostic imaging parameter for assessing a patient’s baseline frailty. Here, we analyzed whether TMT correlates with Traumatic brain injury (TBI) severity and whether it can be used to predict outcome(s) after TBI. Methods: We analyzed the radiological and clinical data sets of 193 patients with TBI who were admitted to our institution and correlated the radiological data with clinical outcomes after stratification for TMT. Results: Our analyses showed a significant association between high TMT and increased risk for intracranial hemorrhage (p = 0.0135) but improved mRS at 6 months (p = 0.001) as compared to patients with low TMT. Congruent with such findings, a lower TMT was associated with falls and reduced outcomes at 6 months (p < 0.0001 and p < 0.0001). Conclusion: High TMT was robustly associated with head trauma sequelae but was also associated with good clinical outcomes in TBI patients. These findings consolidate the significance of TMT as an objective marker of frailty in TBI patients; such measurements may ultimately be leveraged as prognostic indicators.


  • Cerebellar Stroke Score and Grading Scale for the Prediction of Mortality and Outcomes in Ischemic Cerebellar Stroke

    by Sae-Yeon Won, Ruzanna Melkonian, Bedjan Behmanesh, Joshua D. Bernstock, Marcus Czabanka, Daniel Dubinski, Thomas M. Freiman, Albrecht Günther, Kara Hellmuth, Silvia Hernandez-Duran, et al.

    BACKGROUND: Several individual predictors for outcomes in patients with cerebellar stroke (CS) have been previously identified. There is, however, no established clinical score for CS. Therefore, the aim of this study was to develop simple and accurate grading scales for patients with CS in an effort to better estimate mortality and outcomes. METHODS: This multicentric retrospective study included 531 patients with ischemic CS presenting to 5 different academic neurosurgical and neurological departments throughout Germany between 2008 and 2021. Logistic regression analysis was performed to determine independent predictors related to 30-day mortality and unfavorable outcome (modified Rankin Scale score of 4–6). By weighing each parameter via calculation of regression coefficients, an ischemic CS-score and CS-grading scale (CS-GS) were developed and internally validated. RESULTS: Independent predictors for 30-day mortality were aged ≥70 years (odds ratio, 5.2), Glasgow Coma Scale score 3 to 4 at admission (odds ratio, 2.6), stroke volume ≥25 cm 3 (odds ratio, 2.7), and involvement of the brain stem (odds ratio, 3.9). When integrating each parameter into the CS-score, age≥70 years and brain stem stroke were assigned 2 points, Glasgow Coma Scale score 3 to 4, and stroke volume≥25 cm 3 1 point resulting in a score ranging from 0 to 6. CS-score of 0, 1, 2, 3, 4, 5, and 6 points resulted in 30-day mortality of 1%, 6%, 6%, 17%, 21%, 55%, and 67%, respectively. Independent predictors for 30-day unfavorable outcomes consisted of all components of the CS-score with an additional variable focused on comorbidities (CS-GS). Except for Glasgow Coma Scale score 3 to 4 at admission, which was assigned 3 points, all other parameters were assigned 1 point resulting in an overall score ranging from 0 to 7. CS-GS of 0, 1, 2, 3, 4, 5, 6, and 7 points resulted in 30-day unfavorable outcome of 1%, 17%, 33%, 40%, 50%, 80%, 77%, and 100%, respectively. Both 30-day mortality and unfavorable outcomes increased with increasing CS-score and CS-GS ( P <0.001). CONCLUSIONS: The CS-score and CS-GS are simple and accurate grading scales for the prediction of 30-day mortality and unfavorable outcome in patients with CS. While the score systems proposed here may not directly impact treatment decisions, it may help discuss mortality and outcome with patients and caregivers.


  • Open Access

    Prognosis and management of acute symptomatic seizures: a prospective, multicenter, observational study

    by Julia Herzig-Nichtweiß, Farid Salih, Sascha Berning, Michael P. Malter, Johann O. Pelz, Piergiorgio Lochner, Matthias Wittstock, Albrecht Günther, Angelika Alonso, Hannah Fuhrer, et al.